Hyperkalemia Quality Improvement Program (HK-QIP) Study
NCT06884267
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
1000
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperkalemia
Interventions
OTHER:
standard hyperkalemia management implementation
Sponsor
AstraZeneca